Drug Shortage Report for OPTIRAY 320
Report ID | 170406 |
Drug Identification Number | 01900854 |
Brand name | OPTIRAY 320 |
Common or Proper name | Ioversol Injection 68% w/v |
Company Name | LIEBEL-FLARSHEIM COMPANY LLC |
Market Status | MARKETED |
Active Ingredient(s) | IOVERSOL |
Strength(s) | 68% |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVASCULAR INTRAVASCULAR |
Packaging size | 100 mL |
ATC code | V08AB |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2022-07-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-01-04 |
Company comments | Estimated end date remains unknown due to shortage of active ingredient. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8800 DURANT RD. RALEIGH, NORTH CAROLINA UNITED STATES 27616 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-01-04 | French | Compare |
v3 | 2023-01-04 | English | Compare |
v2 | 2022-09-28 | French | Compare |
v1 | 2022-09-28 | English | Compare |
Showing 1 to 4 of 4